Working with Takeda, we’re well positioned to bring a potentially transformative and scalable new therapy to patients.” Finch Therapeutics describes itself as a “microbiome engineering company” and was founded by data scientists, clinicians, and microbiologists from MIT and public stool bank OpenBiome.